MedPath

Continuation Protocol for Obstructive Sleep Apnea (OSA)

Phase 3
Conditions
OSA
Interventions
Registration Number
NCT06566820
Lead Sponsor
Apnimed
Brief Summary

The combination drug composed of aroxybutynin and atomoxetine, designated AD109, is being developed by Apnimed for the treatment of obstructive sleep apnea (OSA). The present study is a Phase 3 open label continuation protocol enrolling qualifying participants who completed one of the parent Phase 3 double-blind placebo-controlled studies, APC-APN-304 or APC-APN-305.

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
1280
Inclusion Criteria
  • Completion of APC-APN-304 without permanent discontinuation of IMP.
  • Completion of APC-APN-305 without permanent discontinuation of IMP.
Exclusion Criteria
  • Participants are excluded from the study if participation would be considered unsafe by the investigator based on the individual's current status.
  • Participants are excluded from the study if participation would be considered unsafe by the investigator based on concomitant therapies.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
AD109Aroxybutynin and AtomoxetineOpen Label AD109
Primary Outcome Measures
NameTimeMethod
Number of Participants With Adverse Events (AES) and Serious Adverse Events (SAEs)through study completion, an average of 1 year

An AE is any untoward medical occurrence in a participant or clinical study participant, temporally associated with the use of a study treatment, whether or not considered related to the medicinal product. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally associated with the use of a study treatment. An SAE was an AE during any study phase that fulfills one or more of the following criteria: results in death, life threatening (The term 'life-threatening' in the definition of 'serious' refers to an event in which the participant was at risk of death at the time of the event. It does not refer to an event, which hypothetically might have caused death, if it were more severe), requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent disability/incapacity.

Number of Participants With Vital Signs Abnormalitiesthrough study completion, an average of 1 year

Vital signs that are planned to be assessed include parameters such as weight,heart rate and systolic and diastolic blood pressure.

Number of Participants With Concomitant Therapy (Medication or Devices)through study completion, an average of 1 year

Concomitant therapy with devices (i.e., CPAP) and concomitant medications are other prescription medications, over-the-counter (OTC) drugs or dietary supplements that a study participant takes in addition to the drug under investigation.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (98)

Desert Clinical Reserach, LLC/CCT Research

🇺🇸

Mesa, Arizona, United States

Foothills Research Center/CCT Research

🇺🇸

Phoenix, Arizona, United States

Fiel Family and Sports Medicine/CCT Research

🇺🇸

Tempe, Arizona, United States

Sleep Disorders Center of America

🇺🇸

Birmingham, Alabama, United States

The University of Alabama/Institute for Rural Health Research

🇺🇸

Tuscaloosa, Alabama, United States

Chandler Clinical Trials

🇺🇸

Chandler, Arizona, United States

Noble Clinical Research

🇺🇸

Tucson, Arizona, United States

Preferred Research Partners, Inc.

🇺🇸

Little Rock, Arkansas, United States

Orange County Research Institute

🇺🇸

Anaheim, California, United States

Core Healthcare Group

🇺🇸

Cerritos, California, United States

Exalt Clinical Research, Inc.

🇺🇸

Chula Vista, California, United States

Collaborative Neuroscience Research, LLC

🇺🇸

Los Alamitos, California, United States

Santa Monica Clinical Trials

🇺🇸

Los Angeles, California, United States

Empire Clinical Research

🇺🇸

Pomona, California, United States

Probe Clinical Research Corporation

🇺🇸

Riverside, California, United States

Pacific Research Network

🇺🇸

San Diego, California, United States

TriValley Sleep Center

🇺🇸

San Ramon, California, United States

SDS Clinical Trials, Inc.

🇺🇸

Santa Ana, California, United States

Providere Research Inc.

🇺🇸

West Covina, California, United States

Mountain View Clinical Research, Inc.

🇺🇸

Denver, Colorado, United States

Meris Clinical Research

🇺🇸

Brandon, Florida, United States

Teradan Clinical Trials

🇺🇸

Brandon, Florida, United States

St. Francis Medical Institute

🇺🇸

Clearwater, Florida, United States

Nouvelle Clinical Research

🇺🇸

Cutler Bay, Florida, United States

Arrow Clinical Trials

🇺🇸

Daytona Beach, Florida, United States

Canvas Clinical Research

🇺🇸

Lake Worth, Florida, United States

Florida Lung & Sleep Associates

🇺🇸

Lehigh Acres, Florida, United States

Ivetmar Medical Group, LLC

🇺🇸

Miami, Florida, United States

Advanced Medical Research Institute

🇺🇸

Miami, Florida, United States

PharmaDev Clinical Research Institute, LLC

🇺🇸

Miami, Florida, United States

Flourish Research

🇺🇸

Miami, Florida, United States

Renstar Medical Research

🇺🇸

Ocala, Florida, United States

Clinical Neuroscience Solutions, Inc.

🇺🇸

Memphis, Tennessee, United States

JSV Clinical Research Study Inc.

🇺🇸

Tampa, Florida, United States

Palm Beach Research Center

🇺🇸

West Palm Beach, Florida, United States

Central Florida Pediatric Sleep Disorders d/b/a Florida Pediatric Institute, LLC

🇺🇸

Winter Park, Florida, United States

Clinical Site Partners, LLC dba Flourish Research

🇺🇸

Winter Park, Florida, United States

Neurotrials Research Inc

🇺🇸

Atlanta, Georgia, United States

Atlanta Center for Medical Research

🇺🇸

Atlanta, Georgia, United States

CenExel iResearch, LLC

🇺🇸

Decatur, Georgia, United States

Georgia Neurology and Sleep Medicine Associates

🇺🇸

Suwanee, Georgia, United States

Medster Research

🇺🇸

Valdosta, Georgia, United States

St. Luke's Idaho Pulmonary Associates - Meridian Clinic

🇺🇸

Meridian, Idaho, United States

Chicago Research Center, Inc.

🇺🇸

Chicago, Illinois, United States

University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

Advanced ENT and Allergy

🇺🇸

Louisville, Kentucky, United States

Centennial Medical Group Research Department

🇺🇸

Columbia, Maryland, United States

Sleep Disorders Centers of the Mid-Atlantic

🇺🇸

Glen Burnie, Maryland, United States

Velocity Clinical Research

🇺🇸

Rockville, Maryland, United States

Neurocare, Inc.

🇺🇸

Newton, Massachusetts, United States

Infinity Medical Research

🇺🇸

North Dartmouth, Massachusetts, United States

Baystate Clinical Trials Unit

🇺🇸

Springfield, Massachusetts, United States

University of Michigan Clinical Research Unit

🇺🇸

Ann Arbor, Michigan, United States

Revive Research Institute, Inc.

🇺🇸

Lathrup Village, Michigan, United States

Henry Ford Medical Center - Columbus

🇺🇸

Novi, Michigan, United States

Clinical Neurophysiology Services PC

🇺🇸

Sterling Heights, Michigan, United States

Sleep Medicine and Research Center, St. Luke's Hospital

🇺🇸

Chesterfield, Missouri, United States

Healthcare Research Network

🇺🇸

Hazelwood, Missouri, United States

Clayton Sleep Institute, LLC

🇺🇸

St. Louis, Missouri, United States

Henderson Clinical Trials

🇺🇸

Henderson, Nevada, United States

Las Vegas Clinical Trials, LLC

🇺🇸

North Las Vegas, Nevada, United States

Clinilabs Drug Development Corporation

🇺🇸

Eatontown, New Jersey, United States

Sleep Dynamics

🇺🇸

Neptune, New Jersey, United States

Maimonides Sleep Arts & Sciences

🇺🇸

Albuquerque, New Mexico, United States

Northwell Health

🇺🇸

New Hyde Park, New York, United States

Research Carolina Elite

🇺🇸

Denver, North Carolina, United States

Clinical Research of Gastonia

🇺🇸

Gastonia, North Carolina, United States

Peters Medical Research LLC

🇺🇸

High Point, North Carolina, United States

Advanced Respiratory and Sleep Medicine

🇺🇸

Huntersville, North Carolina, United States

Coastal Carolina Health Care, P.A. Pulmonary and Sleep Medicine

🇺🇸

New Bern, North Carolina, United States

Accellacare

🇺🇸

Wilmington, North Carolina, United States

Lillestol Research

🇺🇸

Fargo, North Dakota, United States

NeuroScience Research Center, LLC

🇺🇸

Canton, Ohio, United States

CTI Clinical Research Center

🇺🇸

Cincinnati, Ohio, United States

Intrepid Research, LLC

🇺🇸

Cincinnati, Ohio, United States

Northwest Research Center

🇺🇸

Portland, Oregon, United States

Abington Neurological Associates

🇺🇸

Abington, Pennsylvania, United States

Respiratory Specialists

🇺🇸

Wyomissing, Pennsylvania, United States

Lowcountry Lung and Critical Care, PA

🇺🇸

Charleston, South Carolina, United States

Tribe Clinical Research, LLC

🇺🇸

Greenville, South Carolina, United States

Velocity Clinical Research, Greenville

🇺🇸

Greenville, South Carolina, United States

OnSite Clinical Solutions, LLC

🇺🇸

Rock Hill, South Carolina, United States

Chattanooga Research & Medicine

🇺🇸

Chattanooga, Tennessee, United States

FutureSearch Trials of Neurology

🇺🇸

Austin, Texas, United States

FutureSearch Trials of Dallas

🇺🇸

Dallas, Texas, United States

Memorial Hermann Village

🇺🇸

Houston, Texas, United States

Houston Clinical Research Associates

🇺🇸

Houston, Texas, United States

Huntsville Research Institute

🇺🇸

Huntsville, Texas, United States

Sleep Therapy and Research Center

🇺🇸

San Antonio, Texas, United States

Element Research Group

🇺🇸

San Antonio, Texas, United States

South Ogden Family Medicine/CCT Research

🇺🇸

South Ogden, Utah, United States

Sleep Disorder Center of the Mid-Atlantic

🇺🇸

Vienna, Virginia, United States

Medical Arts Health Research Group

🇨🇦

Kelowna, British Columbia, Canada

AMNDX Inc

🇨🇦

Markham, Ontario, Canada

West Ottawa Sleep Centre

🇨🇦

Ottawa, Ontario, Canada

Canadian Phase Onward Inc.

🇨🇦

Toronto, Ontario, Canada

Jodha Tishon, Inc.

🇨🇦

Toronto, Ontario, Canada

McGill University Health Centre

🇨🇦

Montreal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath